Peripheral Neuropathy Treatment Market Analysis, Size, Trends 2020-2024 | Technavio

·4 min read

The peripheral neuropathy treatment market is poised to grow by USD 241.99 million during 2020-2024 progressing at a CAGR of almost 3% during the forecast period.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201126005449/en/

Technavio has announced its latest market research report titled Global Peripheral Neuropathy Treatment Market 2020-2024 (Graphic: Business Wire)

Worried about the impact of COVID-19 on your Business? Here is an Exclusive report talking about Market scenarios, Estimates, the impact of lockdown, and Customer Behaviour.

Get FREE Sample Report in Minutes!

The report on the peripheral neuropathy treatment market provides a holistic update, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis.

The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising awareness of peripheral neuropathy.

The peripheral neuropathy treatment market analysis includes the type segment and geography landscape. This study identifies the development of topical patches as one of the prime reasons driving the peripheral neuropathy treatment market growth during the next few years.

This report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters.

The Peripheral Neuropathy Treatment Market covers the following areas:

Peripheral Neuropathy Treatment Market Sizing

Peripheral Neuropathy Treatment Market Forecast

Peripheral Neuropathy Treatment Market Analysis

Companies Mentioned

  • Daiichi Sankyo Co. Ltd.

  • Eli Lilly and Co.

  • Grunenthal GmbH

  • Hikma Pharmaceuticals Plc

  • Johnson & Johnson

  • Mylan NV

  • Novartis AG

  • Pfizer Inc.

  • Teva Pharmaceutical Industries Ltd.

  • UCB SA

Related Reports on Health Care Include:

Global Neuropathy Pain Treatment Market: The neuropathy pain treatment market size has the potential to grow by $1.70 billion during 2020-2024, and the market’s growth momentum will accelerate during the forecast period because of the steady increase in year-over-year growth. To get extensive research insights: Click and Get FREE Sample Report in Minutes!

Key Topics Covered:

Executive Summary

Market Landscape

  • Market ecosystem

  • Market characteristics

  • Value chain analysis

Market Sizing

  • Market definition

  • Market segment analysis

  • Market size 2019

  • Market outlook: Forecast for 2019 - 2024

Five Forces Analysis

  • Five forces summary

  • Bargaining power of buyers

  • Bargaining power of suppliers

  • Threat of new entrants

  • Threat of substitutes

  • Threat of rivalry

  • Market condition

Market Segmentation by Type

  • Market segments

  • Comparison by Type

  • Diabetic peripheral neuropathy - Market size and forecast 2019-2024

  • Chemotherapy-induced peripheral neuropathy - Market size and forecast 2019-2024

  • Others - Market size and forecast 2019-2024

  • Market opportunity by Type

Customer landscape

Geographic Landscape

  • Geographic segmentation

  • Geographic comparison

  • North America - Market size and forecast 2019-2024

  • Europe - Market size and forecast 2019-2024

  • Asia - Market size and forecast 2019-2024

  • ROW - Market size and forecast 2019-2024

  • Key leading countries

  • Market opportunity by geography

  • Market drivers

  • Market challenges

  • Market trends

Vendor Landscape

  • Competitive scenario

  • Vendor landscape

  • Landscape disruption

Vendor Analysis

  • Vendors covered

  • Market positioning of vendors

  • Daiichi Sankyo Co. Ltd.

  • Eli Lilly and Co.

  • Grunenthal GmbH

  • Hikma Pharmaceuticals Plc

  • Johnson & Johnson

  • Mylan NV

  • Novartis AG

  • Pfizer Inc.

  • Teva Pharmaceutical Industries Ltd.

  • UCB SA

Appendix

  • Scope of the report

  • Currency conversion rates for US$

  • Research methodology

  • List of abbreviations

Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Technavio’s in-depth research has direct and indirect COVID-19 impacted market research reports.

Register for a free trial today and gain instant access to 17,000+ market research reports.

Technavio's SUBSCRIPTION platform

About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

View source version on businesswire.com: https://www.businesswire.com/news/home/20201126005449/en/

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/